Oncologic outcomes and morbidity following heated intraperitoneal chemotherapy at cytoreductive surgery for primary epithelial ovarian cancer: A systematic review and meta-analysis.

CONCLUSION: One randomized trial suggests that HIPEC at time of interval cytoreductive surgery should be considered in patients with primary EOC. However, there is significant heterogeneity in literature with respect to an appropriate HIPEC regimen, short- and long-term outcomes. High-quality prospective randomized trials are urgently needed to clarify the role of HIPEC in the first-line treatment of primary EOC. PMID: 32387131 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32387131?dopt=Abstract

Source: Gynecologic Oncology - May 5, 2020 Category: Cancer & Oncology Authors: Bouchard-Fortier G, Cusimano MC, Fazelzad R, Sajewycz K, Lu L, Espin-Garcia O, May T, Bouchard-Fortier A, Ferguson SE Tags: Gynecol Oncol Source Type: research